07Jan
06Jan
Toy-Sharing Subscriptions Are Gaining In Popularity
Green Piñata Toys focuses on younger children (up to age 5.) With hundreds of toys, including wooden blocks, puzzles, shape sorters and more classic choices, your baby or preschooler can have hours of fun with up to four new toys each month in the subscription box. Green Piñata Toys has a set price of $24.99 and shipping is free. Read more >>
04Jan
Corbus Pharmaceuticals Announces Strategic Collaboration with Kaken Pharmaceutical Co., Ltd. to Develop and Commercialize Lenabasum in Japan for Systemic Sclerosis and Dermatomyositis
Corbus Pharmaceuticals Holdings, Inc. announced today that they have entered into a strategic collaboration with Kaken Pharmaceutical Co., Ltd. ("Kaken") for the development and commercialization in Japan of Corbus' investigational drug lenabasum for the treatment of systemic sclerosis ("SSc") and dermatomyositis ("DM"), two rare and serious autoimmune diseases. Read more >>
26Dec
The dream of sight come true
Joe Marques, who is legally blind, received the gift of sight this year thanks to the generous donations from Book of Dreams readers which bought him a pair of eSight glasses. Read more >>
22Dec
Pixability launches Partner Connect Program to enhance ad campaigns
Pixability, a video advertising software company, has launched the Partner Connect Program, which will provide Pixability’s brand and agency customers with a marketplace of video platforms, as well as creative, data, and measurement solutions. Read more >>
22Dec
Pixability Announces Key Leadership Team Hires
Pixability, the leading provider of insights and optimizations for video advertising across YouTube, Facebook, and Connected TV, announced a pair of strategic new hires to strengthen its executive team. Matt Duffy will be the new Chief Marketing Officer and Lata Ahuja has been hired as the VP of Engineering. Both will help Pixability maintain its strong momentum during this period of rapid growth for the company. Read more >>
19Dec
Corbus Pharma (CRBP) Announces Issuance of Composition of Matter Patent Related to Lenabasum
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical stage drug development company with the industry’s leading pipeline focused on treating inflammatory and fibrotic diseases by targeting the endocannabinoid system, announced today that the U.S. Patent and Trademark Office (“USPTO”) issued Patent No. 10,154,986 to the Company which claims pharmaceutical compositions of lenabasum through 2034. Read more >>
19Dec
How Businesses Are Helping Their Employees Ditch Student Loan Debt
FutureFuel.io, a SaaS platform connecting employers, employees, and student loan servicers, is pushing to “crush” student debt. Read more >>
19Dec
Bloomsburg University Students Using 3D Tech to Pay It Forward
Three years ago, Jesse Johnson, from Northumberland, was given the gift of sight when he received a pair of eSight glasses. Jesse is a junior at Bloomsburg University and has been legally blind since birth. These electronic glasses allow him to see clearly. Read more >>
18Dec